Effect of intravitreal ranibizumab on fibrovascular membranes in patients with proliferative diabetic retinopathy

被引:0
|
作者
Liang, Ze-Yu [1 ]
Wang, Yi-Peng [2 ]
Li, Jing [1 ]
Yang, Wen-Chao [2 ]
Tu, Yong-Fang [2 ]
Zhang, Yue [1 ]
Chen, Song [1 ]
机构
[1] Nankai Univ, Tianjin Eye Hosp, Tianjin Eye Inst, Tianjin Key Lab Ophthalmol & Visual Sci,Affiliated, Tianjin 300020, Peoples R China
[2] Anyang Eye Hosp, Anyang 455000, Henan, Peoples R China
关键词
  proliferative diabetic retinopathy; ranibizumab; fibrovascular membranes; glial-mesenchymal transition; microvessel density; ENDOTHELIAL-CELLS; MULLER GLIA; BEVACIZUMAB; EXPRESSION; MARKER; VEGF;
D O I
10.18240/ijo.2022.10.03
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
? AIM: To assess the effects of intravitreal ranibizumab (IVR) on angiogenesis and glial activity of the fibrovascular membrane (FVM) in patients with proliferative diabetic retinopathy (PDR).? METHODS: Forty-two eyes from 42 patients with PDR requiring vitrectomy were included and divided into two groups: control group (n=16) did not receive IVR, while IVR group (n=26) underwent IVR 5d before vitrectomy. FVM specimens were collected by the same surgeon during the interventions. Histopathological morphology was examined by hematoxylin-eosin (H-E) staining and cell densities in the FVM was assessed. Microvessels were outlined by immunohistochemical staining of CD31 and microvessel density (MVD) assessed as an index of FVM angiogenesis. Dual-color immunofluorescence staining, and confocal microscopy was used to detect co-localization and relative expression levels of glial fibrillary acidic protein (GFAP) and alpha-smooth muscle actin (alpha-SMA) as markers of glial-mesenchymal transition (GMT). The GMT index (GI; ratio of relative GFAP/alpha-SMA expression) was used to semi-quantify the degree of GMT or glial activity of FVMs.? RESULTS: H-E staining showed similar vascularization in both groups, with microvessels and scattered stromal cells in the matrix. Infiltrated cell densities did not differ significantly between the two groups (P>0.05). The MVD of the IVR group (130.62 +/- 15.46/mm2) was significantly lower than that of the controls (142.25 +/- 19.16/mm2, P<0.05). In both groups, all sections were strongly immunostained for GFAP and alpha-SMA. The Pearson's correlation coefficients (PCC) of intensity of automated pixel count of two markers indicated GFAP and alpha-SMA co-stained well and GMT participated in the remolding of FVMs in PDR. The mean relative GFAP expression in the IVR group was significantly lower, whereas that of alpha-SMA was significantly higher than in controls (P<0.05). GI in the IVR group (1.10 +/- 0.10) was significantly lower than in the controls (1.21 +/- 0.12, P<0.05).? CONCLUSION: IVR can reduce angiogenesis, glial activity of FVM and promote glial-fibrotic transformation by reducing MVD and promoting GMT but does not decrease the cell density in patients with PDR.
引用
收藏
页码:1577 / 1585
页数:9
相关论文
共 50 条
  • [21] Intravitreous ranibizumab for proliferative diabetic retinopathy
    Gibson, Jonathan M.
    McGinnigle, Samantha
    NATURE REVIEWS ENDOCRINOLOGY, 2016, 12 (03) : 130 - +
  • [22] Correlations between vitreous cytokine levels and inflammatory cells in fibrovascular membranes of patients with proliferative diabetic retinopathy
    Urbancic, Mojca
    Petrovic, Daniel
    Zivin, Aleksandra Milutinovic
    Korosec, Peter
    Flezar, Matjaz
    Petrovic, Mojca Globocnik
    MOLECULAR VISION, 2020, 26 : 472 - 482
  • [23] A Randomized Trial Evaluating Intravitreal Ranibizumab or Intravitreal Saline for Vitreous Hemorrhage from Proliferative Diabetic Retinopathy
    Bhavsar, Abdhish
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [24] Evaluation of vitrectomy combined preoperative intravitreal ranibizumab and postoperative intravitreal triamcinolone acetonide for proliferative diabetic retinopathy
    Liting Hu
    Qiulu Chen
    Zhaodong Du
    Wenying Wang
    Guiqiu Zhao
    International Ophthalmology, 2021, 41 : 1635 - 1642
  • [25] Evaluation of vitrectomy combined preoperative intravitreal ranibizumab and postoperative intravitreal triamcinolone acetonide for proliferative diabetic retinopathy
    Hu, Liting
    Chen, Qiulu
    Du, Zhaodong
    Wang, Wenying
    Zhao, Guiqiu
    INTERNATIONAL OPHTHALMOLOGY, 2021, 41 (05) : 1635 - 1642
  • [26] EFFICACY OF INTRAVITREAL RANIBIZUMAB INJECTIONS IN THE TREATMENT OF VITREOUS HEMORRHAGE RELATED TO PROLIFERATIVE DIABETIC RETINOPATHY
    Chelala, Elias
    Nehme, Joseph
    El Rami, Hala
    Aoun, Roni
    Dirani, Ali
    Fadlallah, Ali
    Jalkh, Alex
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2018, 38 (06): : 1127 - 1133
  • [27] Tenascin-C promotes angiogenesis in fibrovascular membranes in eyes with proliferative diabetic retinopathy
    Kobayashi, Yoshiyuki
    Yoshida, Shigeo
    Zhou, Yedi
    Nakama, Takahito
    Ishikawa, Keijiro
    Arima, Mitsuru
    Nakao, Shintaro
    Sassa, Yukio
    Takeda, Atsunobu
    Hisatomi, Toshio
    Ikeda, Yasuhiro
    Matsuda, Akira
    Sonoda, Kohhei
    Ishibashi, Tatsuro
    MOLECULAR VISION, 2016, 22 : 436 - 445
  • [28] PDGF as an Important Initiator for Neurite Outgrowth Associated with Fibrovascular Membranes in Proliferative Diabetic Retinopathy
    Lefevere, Evy
    Van Hove, Inge
    Sergeys, Jurgen
    Steel, David H. W.
    Schlingemann, Reinier
    Moons, Lieve
    Klaassen, Ingeborg
    CURRENT EYE RESEARCH, 2022, 47 (02) : 277 - 286
  • [29] Characterization of cells from patient-derived fibrovascular membranes in proliferative diabetic retinopathy
    Kim, Leo A.
    Wong, Lindsay L.
    Amarnani, Dhanesh S.
    Bigger-Allen, Alexander A.
    Hu, Yang
    Marko, Christina K.
    Eliott, Dean
    Shah, Vinay A.
    McGuone, Declan
    Stemmer-Rachamimov, Anat O.
    Gai, Xiaowu
    D'Amore, Patricia A.
    Arboleda-Velasquez, Joseph F.
    MOLECULAR VISION, 2015, 21 : 673 - 687
  • [30] The 'suck-and-cut' bimanual technique for delamination of fibrovascular membranes in proliferative diabetic retinopathy
    Cheema, Rizwan A.
    Sengupta, Rita
    ACTA OPHTHALMOLOGICA SCANDINAVICA, 2007, 85 (02): : 225 - 225